Csilla Rozsa
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.
Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.
Journal: Frontiers in neurology
Published: May 16, 2026
Changes in collateral status during transfer for thrombectomy are predictive of functional outcome in large vessel occlusion stroke.
Journal: GeroScience
Published: February 25, 2026
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
Journal: Journal of neurology
Published: November 01, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Journal: NPJ digital medicine
Published: February 13, 2025
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines Approach.
Journal: Muscle & nerve
Published: January 24, 2025
Reliable Change Indices and Standardized Regression Norms for the Hungarian version of the BICAMS questionnaire.
Journal: Multiple sclerosis and related disorders
Published: January 20, 2025
Explainable time-to-progression predictions in multiple sclerosis.
Journal: Computer methods and programs in biomedicine
Published: July 16, 2024
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
Journal: Journal of medical economics
Published: December 12, 2023
Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial.
Journal: Muscle & nerve
Published: October 24, 2023
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
Journal: PLOS digital health
Published: June 29, 2023
Last Updated: 09/26/2026